Amylyx Pharmaceuticals, Inc.

NasdaqGS:AMLX Stock Report

Market Cap: US$136.2m

Amylyx Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:AMLX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Mar 24SellUS$33,560James FratesIndividual1,792US$18.73
05 Mar 24SellUS$28,841Gina MazzarielloIndividual1,540US$18.73
05 Mar 24SellUS$77,440Justin KleeIndividual4,135US$18.73
05 Mar 24SellUS$77,440Joshua CohenIndividual4,135US$18.73
23 Feb 24SellUS$53,231Gina MazzarielloIndividual2,838US$18.76
09 Jan 24SellUS$45,915Patrick YeramianIndividual2,812US$16.33
09 Jan 24SellUS$95,372Joshua CohenIndividual5,841US$16.33
09 Jan 24SellUS$44,347James FratesIndividual2,716US$16.33
09 Jan 24SellUS$95,372Justin KleeIndividual5,841US$16.33
15 Dec 23BuyUS$59,880Karen FirestoneIndividual4,000US$14.97
25 Sep 23SellUS$51,207,798The Morningside Group LimitedCompany2,305,619US$22.21
16 Aug 23SellUS$39,240,000The Morningside Group LimitedCompany2,000,000US$19.62

Insider Trading Volume

Insider Buying: AMLX insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of AMLX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies12,3140.0154%
Individual Insiders6,836,5558.58%
VC/PE Firms9,995,28012.5%
Institutions62,879,28678.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 85.69% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.55%
ALS Investment Fund
5,795,280US$11.6m0%no data
7.78%
The Vanguard Group, Inc.
5,275,566US$10.6m4.46%no data
6.2%
Panacea Venture Management Co., Ltd.
4,200,000US$8.4m0%18.98%
5.9%
BlackRock, Inc.
4,002,334US$8.0m11.9%no data
4.72%
Point72 Asset Management, L.P.
3,202,381US$6.4m1,330%0.01%
4.37%
Viking Global Investors LP
2,962,555US$6.0m0%0.02%
4.14%
Joshua Cohen
2,808,835US$5.6m0.31%no data
4.05%
Justin Klee
2,745,141US$5.5m0.79%no data
4.03%
Morgan Stanley, Investment Banking and Brokerage Investments
2,733,290US$5.5m231%no data
3.69%
Stonepine Capital Management LLC
2,500,000US$5.0m-0.63%2.52%
3.41%
The Morningside Group Limited
2,313,227US$4.6m0%0.65%
3.35%
Millennium Management LLC
2,272,643US$4.6m7.22%no data
3.31%
Citadel Advisors LLC
2,240,885US$4.5m82.6%no data
2.76%
Perceptive Advisors LLC
1,869,125US$3.8m-30.5%0.09%
2.15%
Emerald Advisers, LLC
1,459,140US$2.9m-4%0.07%
2.13%
State Street Global Advisors, Inc.
1,441,402US$2.9m16.3%no data
2.12%
FMR LLC
1,436,151US$2.9m227%no data
1.95%
Franklin Resources, Inc.
1,322,096US$2.7m115%no data
1.71%
Jane Street Group, LLC, Asset Management Arm
1,157,165US$2.3m92.5%no data
1.65%
Eventide Asset Management, LLC
1,116,837US$2.2m0%0.04%
1.62%
Saturn V Capital Management LP
1,099,268US$2.2m24.1%0.96%
1.57%
Jupiter Fund Management Plc
1,060,900US$2.1m63.3%0.01%
1.52%
Geode Capital Management, LLC
1,030,716US$2.1m4.95%no data
1.5%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
1,019,413US$2.0m2%no data
1.5%
Goldman Sachs Asset Management, L.P.
1,016,175US$2.0m9.07%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.